Interferons at age 50: past, current and future impact on biomedicine
Identifieur interne : 001F25 ( Istex/Curation ); précédent : 001F24; suivant : 001F26Interferons at age 50: past, current and future impact on biomedicine
Auteurs : Ernest C. Borden [États-Unis] ; Ganes C. Sen [États-Unis] ; Gilles Uze [France] ; Robert H. Silverman [États-Unis] ; Richard M. Ransohoff [États-Unis] ; Graham R. Foster [Royaume-Uni] ; George R. Stark [États-Unis]Source :
- Nature Reviews Drug Discovery [ 1474-1776 ] ; 2007-12.
Abstract
The family of interferon (IFN) proteins has now more than reached the potential envisioned by early discovering virologists: IFNs are not only antivirals with a spectrum of clinical effectiveness against both RNA and DNA viruses, but are also the prototypic biological response modifiers for oncology, and show effectiveness in suppressing manifestations of multiple sclerosis. Studies of IFNs have resulted in fundamental insights into cellular signalling mechanisms, gene transcription and innate and acquired immunity. Further elucidation of the multitude of IFN-induced genes, as well as drug development strategies targeting IFN production via the activation of the Toll-like receptors (TLRs), will almost certainly lead to newer and more efficacious therapeutics. Our goal is to offer a molecular and clinical perspective that will enable IFNs or their TLR agonist inducers to reach their full clinical potential.
Url:
DOI: 10.1038/nrd2422
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001F25
Links to Exploration step
ISTEX:E6F16A5249E7EBA21F2651DD0D3AB907DC275B6ELe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Interferons at age 50: past, current and future impact on biomedicine</title>
<author><name sortKey="Borden, Ernest C" sort="Borden, Ernest C" uniqKey="Borden E" first="Ernest C." last="Borden">Ernest C. Borden</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>E-mail: bordene@ccf.org</mods:affiliation>
<wicri:noCountry code="no comma">E-mail: bordene@ccf.org</wicri:noCountry>
</affiliation>
</author>
<author><name sortKey="Sen, Ganes C" sort="Sen, Ganes C" uniqKey="Sen G" first="Ganes C." last="Sen">Ganes C. Sen</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Uze, Gilles" sort="Uze, Gilles" uniqKey="Uze G" first="Gilles" last="Uze">Gilles Uze</name>
<affiliation wicri:level="1"><mods:affiliation>CNRS UMR 5235, Place Eugene Bataillon, Montpellier, Cedex 5 FR34095, France.</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CNRS UMR 5235, Place Eugene Bataillon, Montpellier, Cedex 5 FR34095</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Silverman, Robert H" sort="Silverman, Robert H" uniqKey="Silverman R" first="Robert H." last="Silverman">Robert H. Silverman</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ransohoff, Richard M" sort="Ransohoff, Richard M" uniqKey="Ransohoff R" first="Richard M." last="Ransohoff">Richard M. Ransohoff</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Foster, Graham R" sort="Foster, Graham R" uniqKey="Foster G" first="Graham R." last="Foster">Graham R. Foster</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Cell and Molecular Science, Queen Mary's School of Medicine, 4 Newark Street, London E1 4AT, UK.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Institute of Cell and Molecular Science, Queen Mary's School of Medicine, 4 Newark Street, London E1 4AT</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stark, George R" sort="Stark, George R" uniqKey="Stark G" first="George R." last="Stark">George R. Stark</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:E6F16A5249E7EBA21F2651DD0D3AB907DC275B6E</idno>
<date when="2007" year="2007">2007</date>
<idno type="doi">10.1038/nrd2422</idno>
<idno type="url">https://api.istex.fr/ark:/67375/GT4-KRH340F0-4/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001F25</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001F25</idno>
<idno type="wicri:Area/Istex/Curation">001F25</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Interferons at age 50: past, current and future impact on biomedicine</title>
<author><name sortKey="Borden, Ernest C" sort="Borden, Ernest C" uniqKey="Borden E" first="Ernest C." last="Borden">Ernest C. Borden</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
<affiliation><mods:affiliation>E-mail: bordene@ccf.org</mods:affiliation>
</affiliation>
</author>
<author><name sortKey="Sen, Ganes C" sort="Sen, Ganes C" uniqKey="Sen G" first="Ganes C." last="Sen">Ganes C. Sen</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Uze, Gilles" sort="Uze, Gilles" uniqKey="Uze G" first="Gilles" last="Uze">Gilles Uze</name>
<affiliation wicri:level="1"><mods:affiliation>CNRS UMR 5235, Place Eugene Bataillon, Montpellier, Cedex 5 FR34095, France.</mods:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>CNRS UMR 5235, Place Eugene Bataillon, Montpellier, Cedex 5 FR34095</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Silverman, Robert H" sort="Silverman, Robert H" uniqKey="Silverman R" first="Robert H." last="Silverman">Robert H. Silverman</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Ransohoff, Richard M" sort="Ransohoff, Richard M" uniqKey="Ransohoff R" first="Richard M." last="Ransohoff">Richard M. Ransohoff</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Foster, Graham R" sort="Foster, Graham R" uniqKey="Foster G" first="Graham R." last="Foster">Graham R. Foster</name>
<affiliation wicri:level="1"><mods:affiliation>Institute of Cell and Molecular Science, Queen Mary's School of Medicine, 4 Newark Street, London E1 4AT, UK.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">Royaume-Uni</country>
<wicri:regionArea>Institute of Cell and Molecular Science, Queen Mary's School of Medicine, 4 Newark Street, London E1 4AT</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Stark, George R" sort="Stark, George R" uniqKey="Stark G" first="George R." last="Stark">George R. Stark</name>
<affiliation wicri:level="1"><mods:affiliation>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.</mods:affiliation>
<country xml:lang="fr" wicri:curation="lc">États-Unis</country>
<wicri:regionArea>Taussig Cancer Center, Case Comprehensive Cancer Center, Mellen Center for Multiple Sclerosis, and Lerner Research Institute, The Cleveland Clinic, 9500 Euclid Avenue, Cleveland, Ohio 44195</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Nature Reviews Drug Discovery</title>
<idno type="ISSN">1474-1776</idno>
<idno type="eISSN">1474-1784</idno>
<imprint><publisher>Nature Publishing Group</publisher>
<date when="2007-12">2007-12</date>
<biblScope unit="vol">6</biblScope>
<biblScope unit="issue">12</biblScope>
<biblScope unit="page" from="975">975</biblScope>
<biblScope unit="page" to="990">990</biblScope>
<date type="Copyright" when="2007">2007</date>
</imprint>
<idno type="ISSN">1474-1776</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">1474-1776</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="eng">The family of interferon (IFN) proteins has now more than reached the potential envisioned by early discovering virologists: IFNs are not only antivirals with a spectrum of clinical effectiveness against both RNA and DNA viruses, but are also the prototypic biological response modifiers for oncology, and show effectiveness in suppressing manifestations of multiple sclerosis. Studies of IFNs have resulted in fundamental insights into cellular signalling mechanisms, gene transcription and innate and acquired immunity. Further elucidation of the multitude of IFN-induced genes, as well as drug development strategies targeting IFN production via the activation of the Toll-like receptors (TLRs), will almost certainly lead to newer and more efficacious therapeutics. Our goal is to offer a molecular and clinical perspective that will enable IFNs or their TLR agonist inducers to reach their full clinical potential.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 001F25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Istex |étape= Curation |type= RBID |clé= ISTEX:E6F16A5249E7EBA21F2651DD0D3AB907DC275B6E |texte= Interferons at age 50: past, current and future impact on biomedicine }}
This area was generated with Dilib version V0.6.33. |